Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1260-1264, 2006
DOI: 10.2337/db05-0620
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hara, K.
Right arrow Articles by Kadowaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hara, K.
Right arrow Articles by Kadowaki, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Genetics Reports

Hepatocyte Nuclear Factor-4{alpha} P2 Promoter Haplotypes Are Associated With Type 2 Diabetes in the Japanese Population

Kazuo Hara1,2,3,4, Momoko Horikoshi1, Hiroji Kitazato5, Chikako Ito6, Mitsuhiko Noda7, Jun Ohashi8, Philippe Froguel9, Katsushi Tokunaga8, Kazuyuki Tobe1,3, Ryozo Nagai2,10, and Takashi Kadowaki1,3,4

1 Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2 Department of Clinical Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3 CREST, Japan Science and Technology Corporation (JST), Tokyo, Japan
4 National Institute of Health and Nutrition, Tokyo, Japan
5 Institute for Diabetes Care and Research, Asahi Life Foundation, Tokyo, Japan
6 Hiroshima Atomic Bomb Casualty Council Health Management Center, Hiroshima, Japan
7 Department of Endocrinology and Metabolism, International Medical Center of Japan, Tokyo, Japan
8 Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
9 CNRS 8090, Institut de Biologie de Lille, Institute Pasteur and CHU Lille, Lille, France
10 Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Address correspondence and reprint requests to Dr. Takashi Kadowaki, Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: kadowaki-3im{at}h.u-tokyo.ac.jp

Abbreviations: HNF, hepatocyte nuclear factor; LD, linkage disequilibrium; MODY, maturity-onset diabetes of the young; SNP, single nucleotide polymorphism

Hepatocyte nuclear factor (HNF)-4{alpha} is a transcription factor known as a key molecule in the development and functions of the ß-cells. In a previously performed genome-wide scan of Japanese type 2 diabetic sibpairs, we observed linkage of type 2 diabetes to chromosome 20q12-q13, a region in which the HNF4A gene is located. Recent studies have reported associations between type 2 diabetes and polymorphisms in the P2 promoter region specific to ß-cells. In this study, we attempted to assess whether the HNF4A gene plays a role in the genetic susceptibility to type 2 diabetes in the Japanese population by analyzing polymorphisms and haplotypes of the HNF4A gene. Linkage disequilibrium across the P2 promoter region was preserved in the Japanese population, consistent with previous reports. Although none of the individual polymorphisms examined showed any significant association with type 2 diabetes, we found very strong evidence of the association between type 2 diabetes and the haplotype consisting of two polymorphisms in the P2 promoter region of the HNF4A gene (P = 3.82 x 10–4). In contrast, there was no association between type 2 diabetes and haplotypes consisting of polymorphisms not located in the P2 promoter region, suggesting that the type 2 diabetes susceptibility loci are localized in the P2 promoter region of the HNF4A gene. The association was replicated using two additional cohorts (P = 1.51 x 10–4 and 0.019, respectively). The results of the present analysis revealed that the HNF4A gene might be a type 2 diabetes susceptibility gene common to different ethnic groups. The study also suggested the possible existence of an as-yet-unidentified but functional polymorphism in the P2 promoter region of the HNF4A gene that directly influences susceptibility to type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Johansson, H. Raeder, S. A Eide, K. Midthjell, K. Hveem, O. Sovik, A. Molven, and P. R. Njolstad
Studies in 3,523 Norwegians and Meta-Analysis in 11,571 Subjects Indicate That Variants in the Hepatocyte Nuclear Factor 4{alpha} (HNF4A) P2 Region Are Associated With Type 2 Diabetes in Scandinavians
Diabetes, December 1, 2007; 56(12): 3112 - 3117.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. M. Lehman, D. K. Richardson, C. P. Jenkinson, K. J. Hunt, T. D. Dyer, R. J. Leach, R. Arya, H. E. Abboud, J. Blangero, R. Duggirala, et al.
P2 Promoter Variants of the Hepatocyte Nuclear Factor 4{alpha} Gene Are Associated With Type 2 Diabetes in Mexican Americans
Diabetes, February 1, 2007; 56(2): 513 - 517.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Freeman and R.D. Cox
Type-2 diabetes: a cocktail of genetic discovery
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R202 - R209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.